Dulcolax

GPTKB entity

Statements (47)
Predicate Object
gptkbp:instance_of gptkb:disease
gptkbp:available_on gptkb:pharmaceuticals
gptkbp:brand gptkb:Dulcolax
Dulcolax Liquid
Dulcolax Stool Softener
Dulcolax Suppositories
gptkbp:category Category B
gptkbp:clinical_use bowel preparation before surgery
preparation for diagnostic procedures
short-term treatment of constipation
gptkbp:contraindication gptkb:Crohn's_disease
gptkb:ulcerative_colitis
severe dehydration
appendicitis
intestinal obstruction
gptkbp:dosage_form oral tablet
rectal suppository
10 mg rectally
5 to 15 mg orally
gptkbp:financial_support consult a doctor if symptoms persist
do not exceed recommended dosage
gptkbp:form gptkb:tablet
suppository
https://www.w3.org/2000/01/rdf-schema#label Dulcolax
gptkbp:ingredients bisacodyl
gptkbp:interacts_with antacids
diuretics
other laxatives
gptkbp:manufacturer gptkb:Boehringer_Ingelheim
gptkbp:premiered_on 15 to 60 minutes rectally
6 to 12 hours orally
gptkbp:release_region gptkb:Australia
gptkb:Canada
gptkb:Germany
gptkb:United_Kingdom
gptkb:United_States
gptkbp:route_of_administration oral
rectal
gptkbp:side_effect dizziness
nausea
diarrhea
abdominal cramping
gptkbp:storage room temperature
away from moisture
gptkbp:used_for constipation
gptkbp:bfsParent gptkb:Pfizer_Consumer_Healthcare
gptkbp:bfsLayer 5